Holen Sie sich die Stockscreener-App
7.51
5.63%
0.40
Certara Inc Aktie (CERT) Neueste Nachrichten
Certara, Inc. (CERT) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Certara, Inc. (CERT) Stock Forecasts - Yahoo! Finance Canada
Technical Reactions to CERT Trends in Macro Strategies - Stock Traders Daily
How Certara’s NVIDIA AI Partnership Could Reshape CERT’s Long-Term Drug Development Narrative - webull.com
Certara Inc. (CERT) Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesEarnings Sentiment Score - dars.gov.et
Certara Inc. (CERT) Slides 4.8% as Shares Test Key Support LevelsCollar Trade - dars.gov.et
Certara files Form 3 for interim CFO Mohammed Faiz initial beneficial ownership statement - Bitget
Certara (CERT) interim CFO discloses stock, RSU and PSU holdings - Stock Titan
Why Did CERT Stock Fall Today? - Stocktwits
Certara to report Q2 2026 financial results on August 4 - scanx.trade
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026 - The Manila Times
Certara sets Aug. 4 call to discuss second-quarter results - Stock Titan
BlackRock, Inc.'s Strategic Acquisition of Certara Inc. Shares - GuruFocus
Pomerantz investigates Certara investors over p... - Pluang
Dimensional Fund Advisors details Certara Inc (CERT) 3.9% ownership position - Stock Titan
What Certara (CERT)'s NVIDIA BioNeMo Partnership Means For Shareholders - Sahm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc.CERT - PR Newswire
BlackRock (CERT) discloses 18.0M shares; 11.6% ownership reported - Stock Titan
AI Chips TodayCertara-NVIDIA Partnership Revolutionizes AI in Drug Development - Yahoo Finance
Certara partners with Nvidia to integrate AI agents into drug development platform - Investing.com UK
Nvidia Powers AI Agent Strategies for Certara, Silo PharmaNVIDIA (NASDAQ:NVDA) - Benzinga
Certara teams up with Nvidia to strengthen AI platform with BioNeMo toolkit (CERT) - Yahoo Finance
Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit - The Manila Times
Certara Accelerates Drug Discovery and Development With NVIDIA BioNeMo Agent Toolkit - 富途牛牛
Certara, Silo Pharma advance AI strategies with Nvidia initiatives - scanx.trade
Price to earnings forward of Certara, Inc. – HAM:700 - TradingView
Enterprise value to revenue forward of Certara, Inc. – NASDAQ:CERT - TradingView
Price to sales forward of Certara, Inc. – HAM:700 - TradingView
Certara Inc (NASDAQ: CERT) Share Price, CERT Stock News, CERT Share Price & Updates - Kalkine
Is Certara (CERT) Quietly Recasting Its Small-Cap Identity Around Biosimulation Advisory Leadership? - Yahoo Finance
Does Certara (CERT) Joining the Russell 2000 Recast Its Biosimulation Investment Narrative? - simplywall.st
CERT Q1 2026 Earnings: EPS Misses Estimates but Stock Rises 2.75%Share Dilution Risk - DonanımHaber
Trading the Move, Not the Narrative: (CERT) Edition - Stock Traders Daily
William Blair Maintains Certara(CERT.US) With Hold Rating - Moomoo
Should You Investigate Certara, Inc. (NASDAQ:CERT) At US$6.36? - Moomoo
Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Pomerantz investigates Certara after revenue drop and CFO exit - scanx.trade
Certara Inc. (CERT) Rallies 8.9% – Key Support and Resistance Levels in FocusDealer Positioning - dars.gov.et
Certara, Inc.(NasdaqGS: CERT) added to Russell 2000 Index - marketscreener.com
Certara, Inc.(NasdaqGS: CERT) dropped from Russell Midcap Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Certara, Inc. – NASDAQ:CERT - TradingView
Certara, Inc.(NasdaqGS: CERT) dropped from Russell 1000 Dynamic Index - marketscreener.com
Enterprise value to EBIT forward of Certara, Inc. – NASDAQ:CERT - TradingView
Certara, Inc.(NasdaqGS: CERT) dropped from Russell Midcap Index - marketscreener.com
Price to book forward of Certara, Inc. – NASDAQ:CERT - TradingView
Price to book forward of Certara, Inc. – BMV:CERT - TradingView
Price to earnings forward of Certara, Inc. – BMV:CERT - TradingView
[Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Certara, Inc. Actuals & Estimates (NASDAQ:CERT) - TradingView
CERT Forecast — Price Target — Prediction for 2027 - TradingView
Certara Q1 2026 Earnings: EPS Misses Estimates Amid Challenging QuarterAnalyst Consensus Shift - dars.gov.et
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-Risk Investment and Accelerate Development - marketscreener.com
CERT Stock Slides As Certara Faces Probes And CFO Exit - timothysykes.com
Certara StockLaw Firm Launches Investigation After Share Price Slide - AD HOC NEWS
Certara names Faiz Mohammed interim CFO as John Gallagher steps down - MSN
Certara (CERT) Stock Sees Fair Value Edges Lower As Analysts Trim Targets - Yahoo Finance
1.99%
2.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):